Join to View Full Profile
400 Parnassus AveFl 4San Francisco, CA 94143
Phone+1 415-353-2421
Fax+1 650-498-6205
Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Alfred Chung, MD is an oncologist based in San Francisco, CA, with a subspecialty in Hematologic Oncology. He completed his education at Northwestern University The Feinberg School of Medicine in 2014. Dr. Chung has contributed to multiple publications, with notable works in the fields of hematologic oncology and myeloma treatment. His research has been published in various reputable journals including Blood Advances, The American Journal of Medicine, and Leukemia & Lymphoma, among others.
Education & Training
Northwestern University The Feinberg School of MedicineClass of 2014
Certifications & Licensure
CA State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?Arvind Suresh, Darren Pan, Jodi Lipof, Anupama Kumar, Shagun Arora
Immunotherapy. 2025-10-01 - 6 citationsTargeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik S Kang, Nikhil Chilakapati
Blood. 2025-08-14 - 1 citationsScreening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.Ping Zhou, Mahesh M Mansukhani, Raymond Yeh, Jiesheng Lu, Hongai Xia
Journal of Clinical Medicine. 2025-06-11
Lectures
- Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
